UBS Group’s NeueHealth NEUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-24,967
| Closed | -$167K | – | 11276 |
|
|
2025
Q3 | $167K | Sell |
24,967
-6,645
| -21% | -$44.8K | ﹤0.01% | 6777 |
|
|
2025
Q2 | $218K | Sell |
31,612
-5,113
| -14% | -$34.4K | ﹤0.01% | 6661 |
|
|
2025
Q1 | $248K | Sell |
36,725
-3,814
| -9% | -$26.7K | ﹤0.01% | 6389 |
|
|
2024
Q4 | $301K | Buy |
40,539
+36,753
| +971% | +$195K | ﹤0.01% | 6197 |
|
|
2024
Q3 | $19.8K | Buy |
3,786
+2,224
| +142% | +$11.8K | ﹤0.01% | 7381 |
|
|
2024
Q2 | $8.5K | Buy |
1,562
+1,498
| +2,341% | +$8.91K | ﹤0.01% | 7799 |
|
|
2024
Q1 | $416 | Sell |
64
-259
| -80% | -$2.31K | ﹤0.01% | 8573 |
|
|
2023
Q4 | $2.46K | Buy |
323
+132
| +69% | +$887 | ﹤0.01% | 8105 |
|
|
2023
Q3 | $1.14K | Buy |
191
+126
| +194% | +$1.29K | ﹤0.01% | 8080 |
|
|
2023
Q2 | $794 | Sell |
65
-770
| -92% | -$10.2K | ﹤0.01% | 8095 |
|
|
2023
Q1 | $14.7K | Buy |
835
+46
| +6% | +$2.37K | ﹤0.01% | 7328 |
|
|
2022
Q4 | $41K | Buy |
789
+505
| +178% | +$36.7K | ﹤0.01% | 6955 |
|
|
2022
Q3 | $24K | Sell |
284
-1,105
| -80% | -$147K | ﹤0.01% | 7163 |
|
|
2022
Q2 | $202K | Sell |
1,389
-7,523
| -84% | -$1.09M | ﹤0.01% | 4900 |
|
|
2022
Q1 | $1.38M | Buy |
8,912
+8,660
| +3,437% | +$1.92M | ﹤0.01% | 3792 |
|
|
2021
Q4 | $69K | Buy |
252
+48
| +24% | +$22.2K | ﹤0.01% | 6643 |
|
|
2021
Q3 | $133K | Buy |
204
+199
| +3,980% | +$175K | ﹤0.01% | 5626 |
|
|
2021
Q2 | $7K | Buy |
+5
| New | +$6.85K | ﹤0.01% | 8358 |
|
UBS Group's NEUE Position: Q4 2025 in Review
UBS Group sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 24,967 shares — an estimated $167K sold.
UBS Group first reported a position in NEUE in Q2 2021 and held it in 18 quarters. The position peaked at $1.38M in Q1 2022. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.
- UBS Group reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
- UBS Group sold 24,967 NeueHealth shares in Q4 2025, an estimated $167K.
- UBS Group first reported a position in NeueHealth in Q2 2021 and held it in 18 quarters.
- UBS Group's NeueHealth position peaked at $1.38M in Q1 2022.
- 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.